Valinomycin
CAS: 2001-95-8
Ref. 3D-AV28656
25mg | 190,00 € | ||
50mg | 303,00 € | ||
100mg | 447,00 € | ||
250mg | 732,00 € | ||
500mg | 1.054,00 € |
Información del producto
- Valinomycin1Cyclo(D-a-hydroxyisovaleryl-D-valyl-L-lactoyl-L-valyl-D-a-hydroxyisovaleryl-D-valyl-L-lactoyl-L-valyl-D-a-hydroxyisoval eryl-D-valyl-L-lactoyl-L-valyl)NSC 122023
- 1,7,13,19,25,31-Hexaoxa-4,10,16,22,28,34-hexaazacyclohexatriacontane-2,5,8,11,14,17,20,23,26,29,32,35-dodecone, 3,6,9,15,18,21,27,30,33-nonaisopropyl-12,24,36-trimethyl-
- Cyclo(D-α-hydroxyisovaleryl-D-valyl-L-lactoyl-L-valyl-D-α-hydroxyisovaleryl-D-valyl-L-lactoyl-L-valyl-D-α-hydroxyisovaleryl-D-valyl-L-lactoyl-L-valyl)
- Nsc 122023
- Valinomicin
- Valinomicina
- Valinomycine
Valinomycin is a drug that acts as an inhibitor of the mitochondrial membrane potential and can be used as a model system for studying mitochondrial functions. Valinomycin binds to the cytosolic Ca2+ ion channel and prevents its opening, preventing the release of Ca2+ ions from the cell. This leads to an increase in the mitochondrial membrane potential, which is accompanied by an increase in ATP synthesis. Valinomycin also inhibits drug transporter proteins, including P-glycoprotein, thus making it useful for treating cancer. Valinomycin has been shown to have several physiological effects such as increasing energy metabolism and inhibiting transfer reactions, which are involved in various metabolic pathways.
Propiedades químicas
Consulta técnica sobre: 3D-AV28656 Valinomycin
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.